IRIS
PATRONE, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.114
Totale 21.114
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.114
Totale 21.114
Salva come PNG Salva come JPEG
Città #
Genova 15.082
Genoa 2.497
Rapallo 2.204
Vado Ligure 1.289
Bordighera 42
Totale 21.114
Salva come PNG Salva come JPEG
Nome #
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 193
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 190
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 189
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 187
Autophagy in blood cancers: biological role and therapeutic implications. 185
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 184
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 179
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 172
APO866 activity in hematologic malignancies: a preclinical in vitro study. 169
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 165
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 164
Anticancer vaccination strategies. 163
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 163
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. 159
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 157
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 157
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 155
Ras-induced resistance to lapatinib is overcome by MEK inhibition 154
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 154
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 153
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 152
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 152
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 150
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 149
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 149
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 145
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 143
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 143
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 143
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 142
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 141
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 141
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 140
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 137
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 136
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. 136
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 136
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 136
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 134
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 134
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 132
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 132
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 128
In vitro effects of synthetic chemotactic peptides on neutrophil function. 128
A simple acid-precipitation test for rapid screening of monoclonal gammopathies. 128
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 128
New insights into biology of chronic myeloid leukemia: implications in therapy. 127
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. 127
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 126
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 125
The use of dendritic cells in cancer immunotherapy. 125
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 124
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. 124
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 124
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 124
Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. 123
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide and cisplatin (CEP) 122
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. 122
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 120
Stimulation of neutrophil locomotion by inosiplex. 120
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 119
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer 118
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 118
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 117
Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. 117
Neutrophil functions in acne conglobata. 117
Hyperimmunoglobulinemia E syndrome. 117
Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells. 117
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 117
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 117
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 116
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 116
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 116
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 115
The proteasome and its inhibitors in immune regulation and immune disorders. 115
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 114
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. 114
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 113
Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. 113
Autologous peripheral blood stem cells (PBSC) in breast cancer. 112
Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. 111
Neutrophil chemotaxis: physiology and pathology. 111
[Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method]. 111
Proteasome inhibitors: antitumor effects and beyond 111
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 111
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 110
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 109
Target cell lysis mediated by concanavalin A-triggered human neutrophils. 109
Evidence for a reversible functional state of neutrophil chemotactic deactivation. 109
Immunopathological studies on a case of Sweet's syndrome. 107
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. 107
Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation. 107
Intracellular NAD+ depletion induces autophagic-death in Multiple Myeloma cells 107
Extracellular cytolysis by leukaemic blast cells. 105
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 105
Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation. 105
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. 105
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 104
Normal polymorphonuclear neutrophil function in a case of glycogen storage disease type Ib. 103
Defective neutrophil chemotaxis and bactericidal power in a child with hyperimmunoglobulinemia E. 103
Totale 13.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.442
article - articoli 55.349
book - libri 0
conference - conferenze 332
curatela - curatele 0
other - altro 0
patent - brevetti 79
selected - selezionate 0
volume - volumi 682
Totale 112.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.384 0 0 0 0 0 0 0 299 389 904 585 207
2020/20211.243 109 100 71 77 80 130 76 106 130 116 145 103
2021/20222.402 57 182 172 256 176 144 128 536 78 243 109 321
2022/20232.651 270 195 18 290 437 490 12 199 462 12 241 25
2023/20241.256 44 159 23 148 99 268 43 140 54 21 64 193
2024/20252.126 109 270 95 213 454 272 296 417 0 0 0 0
Totale 21.214